Conditions: Bipolar Depression
Keywords: Bipolar I Depression Lurasidone Latuda
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 356
Healthy volunteers: no

Brief summary:
Lurasidone HCI is a compound that is a candidate for the treatment of bipolar I depression. This clinical study is designed to test the hypothesis that Lurasidone in combination with either Lithium or Divalproex is effective among patients with bipolar I depression.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Lurasidone intervention 2: Placebo
Intervention descriptions: intervention 1: Tablets 20-120 mg, PM dosing,daily for 6 weeks intervention 2: Equivalent to Lurasidone dosing

Protocol document: